Rock Springs Capital Management LP
Baltimore MD · SEC CIK 0001595725
$16.97亿2026Q1 申报市值
100持仓数
40.6%前十大占比 · 第一大 6.9%
11 / 10新建仓 / 清仓
26Q126Q2
前十大持仓 占组合比例
2026Q1 买入最多 按季末市值估算
MDGL 加仓+$1,642.70万
MMED 新建仓+$1,574.06万
BSX 加仓+$729.47万
HTFL 加仓+$717.25万
PTCT 加仓+$680.75万
2026Q1 卖出最多 按季末市值估算
EXACT SCIENCES C 清仓-$6,111.88万
CIDARA THERAPEUT 清仓-$4,525.55万
AMICUS THERAPEUT 减仓-$2,760.23万
XBI 减仓-$2,452.42万
TVTX 减仓-$2,175.87万
2026Q1 持仓明细 点表头排序 · 每页 100 行
导出 CSV 🔒| 代码 | 名称 | 市值 ▼ | 占比 | 股数 | 变动股数 | 变动 | 估算买卖额 | 操作 |
|---|---|---|---|---|---|---|---|---|
| — | EXACT SCIENCES CORP | $0 | 0.00% | 0 | -601,800 | -100.0% | -$6,111.88万 | 清仓 |
| — | CIDARA THERAPEUTICS INC | $0 | 0.00% | 0 | -204,878 | -100.0% | -$4,525.55万 | 清仓 |
| — | RAPT THERAPEUTICS INC | $0 | 0.00% | 0 | -213,731 | -100.0% | -$723.91万 | 清仓 |
| — | GOSSAMER BIO INC | $0 | 0.00% | 0 | -9,573,000 | -100.0% | -$655.90万 | 清仓 |
| — | AGILON HEALTH INC | $0 | 0.00% | 0 | -6,500,000 | -100.0% | -$447.65万 | 清仓 |
| — | MERSANA THERAPEUTICS INC | $0 | 0.00% | 0 | -152,586 | -100.0% | -$441.43万 | 清仓 |
| — | THERAVANCE BIOPHARMA INC | $0 | 0.00% | 0 | -208,771 | -100.0% | -$390.61万 | 清仓 |
| — | INDIVIOR PLC | $0 | 0.00% | 0 | -105,100 | -100.0% | -$377.10万 | 清仓 |
| NAMS | NEWAMSTERDAM PHARMA COMPANY 看涨期权 | $0 | 0.00% | 0 | -31,600 | -100.0% | -$110.85万 | 清仓 |
| — | NUVATION BIO INC | $0 | 0.00% | 0 | -134,028 | -100.0% | -$4.42万 | 清仓 |